We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
S
401
PUT
DELISTED
Sprint Corporation
S
| $1.96M | 0.03% |
471,300
+466,672
| +10,084% | +$2.4M |
|
|
OPLN
402
Openlane
OPLN
$4.28B
| $1.95M | 0.03% |
148,607
+97,770
| +192% | +$1.18M |
|
403
Biogen
BIIB
$30.9B
| $1.94M | 0.03% |
+5,715
| New | +$1.85M |
|
404
Apple
AAPL
$4.97T
| $1.93M | 0.03% |
69,960
-327,472
| -82% | -$8.91M |
|
|
ZOES
405
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $1.92M | 0.03% |
64,011
-21,518
| -25% | -$697K |
|
|
SBNY
406
DELISTED
Signature Bank
SBNY
| $1.91M | 0.03% |
15,127
-66,843
| -82% | -$7.98M |
|
407
Molson Coors Class B
TAP
$8.02B
| $1.9M | 0.03% |
+25,500
| New | +$1.89M |
|
408
CALL
Akamai
AKAM
$15.6B
| $1.9M | 0.03% |
+30,100
| New | +$1.81M |
|
409
PUT
CarMax
KMX
$8.39B
| $1.86M | 0.03% |
27,900
+27,713
| +14,820% | +$1.54M |
|
410
PVH
PVH
$4.07B
| $1.85M | 0.03% |
14,451
+9,998
| +225% | +$1.2M |
|
|
WBA
411
DELISTED
Walgreens Boots Alliance
WBA
| $1.78M | 0.03% |
23,400
-114,915
| -83% | -$7.68M |
|
|
MRGE
412
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $1.78M | 0.03% |
500,000
| – | – |
|
|
IMRS
413
DELISTED
IMRIS INC COMMON SHARES (CANADA)
IMRS
| $1.78M | 0.03% |
2,109,110
+24,750
| +1% | +$9.36K |
|
414
New Oriental
EDU
$9.32B
| $1.76M | 0.02% |
+86,303
| New | +$1.87M |
|
415
Generac Holdings
GNRC
$11.5B
| $1.76M | 0.02% |
+37,566
| New | +$1.64M |
|
416
Boise Cascade
BCC
$2.73B
| $1.75M | 0.02% |
+47,070
| New | +$1.62M |
|
|
VRNT
417
DELISTED
Verint Systems
VRNT
| $1.75M | 0.02% |
58,890
-59,086
| -50% | -$1.72M |
|
|
TFCF
418
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $1.75M | 0.02% |
47,404
-363,918
| -88% | -$12.4M |
|
419
Analog Devices
ADI
$172B
| $1.73M | 0.02% |
31,080
+11,603
| +60% | +$592K |
|
420
Expedia Group
EXPE
$36.5B
| $1.72M | 0.02% |
20,109
+15,149
| +305% | +$1.28M |
|
421
GSK
GSK
$107B
| $1.71M | 0.02% |
+32,000
| New | +$1.79M |
|
422
Exelon
EXC
$48.1B
| $1.7M | 0.02% |
64,369
-1,372,586
| -96% | -$35.2M |
|
423
Carter's
CRI
$1.43B
| $1.69M | 0.02% |
19,318
-682
| -3% | -$55K |
|
424
Conagra Brands
CAG
$7.42B
| $1.69M | 0.02% |
59,661
+21,247
| +55% | +$582K |
|
425
PUT
United Airlines
UAL
$38.8B
| $1.67M | 0.02% |
+25,000
| New | +$1.38M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.